797398608	797398608	CD	B-NP	O
|	|	NN	I-NP	O
LH	LH	NN	I-NP	O
|	|	NN	I-NP	O
77041520	77041520	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
5191031	5191031	CD	B-NP	O
|	|	CC	I-NP	O
9/15/2005	9/15/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
SEPTIC	SEPTIC	NNP	I-NP	I-protein
SHOCK	SHOCK	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Signed	Signed	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/8/2005	11/8/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/10/2005	9/10/2005	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
RUCKEL	RUCKEL	NN	B-NP	O
,	,	,	O	O
KENDALL	KENDALL	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	NNP	B-NP	O
ILLNESS	ILLNESS	NNP	I-NP	O
:	:	:	O	O
In	In	IN	B-PP	O
brief	brief	NN	B-NP	O
,	,	,	O	O
this	this	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
64-year-old	64-year-old	JJ	I-NP	O
male	male	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
prior	prior	JJ	I-NP	O
echo	echo	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
,	,	,	O	O
PE	PE	NN	B-NP	O
,	,	,	O	O
DVT	DVT	NN	B-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
OSA	OSA	NN	B-NP	B-protein
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
,	,	,	O	O
hematuria	hematuria	NN	B-NP	O
,	,	,	O	O
dysuria	dysuria	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
right	right	RB	B-ADVP	O
back	back	RB	I-ADVP	O
pain	pain	NN	B-NP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
requiring	require	VBG	B-VP	O
vasopressin	vasopressin	NN	B-NP	O
for	for	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
support	support	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
Medical	Medical	NNP	I-NP	O
ICU	ICU	NNP	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
respond	respond	VB	I-VP	O
to	to	TO	B-PP	O
vasopressor	vasopressor	NN	B-NP	O
regimen	regimen	NN	I-NP	O
and	and	CC	O	O
unclear	unclear	JJ	B-NP	O
relative	relative	JJ	I-NP	O
contribution	contribution	NN	I-NP	O
of	of	IN	B-PP	O
distributive	distributive	JJ	B-NP	O
verus	verus	NN	I-NP	O
cardiogenic	cardiogenic	JJ	I-NP	O
shock	shock	NN	I-NP	O
.	.	.	O	O

Electively	Electively	RB	B-ADVP	O
intubated	intubate	VBN	B-VP	O
in	in	IN	B-PP	O
an	an	DT	B-NP	O
anticipation	anticipation	NN	I-NP	O
of	of	IN	B-PP	O
procedures	procedure	NNS	B-NP	O
given	give	VBN	B-VP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

Swan	Swan	NN	B-NP	O
numbers	number	NNS	I-NP	O
were	be	VBD	B-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
distributive	distributive	JJ	B-NP	O
shock	shock	NN	I-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
with	with	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
and	and	CC	O	O
urine	urine	NN	B-NP	O
culture	culture	NN	I-NP	O
and	and	CC	O	O
sputum	sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
had	have	VBD	B-VP	O
evidence	evidence	NN	B-NP	O
of	of	IN	B-PP	O
prostatitis	prostatitis	NN	B-NP	O
and	and	CC	O	O
acalculous	acalculous	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
biliary	biliary	JJ	I-NP	I-protein
drain	drain	NN	I-NP	I-protein
with	with	IN	B-PP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
desensitization	desensitization	NN	B-NP	O
for	for	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
for	for	IN	B-PP	O
quinolone-resistant	quinolone-resistant	JJ	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
improved	improve	VBD	B-VP	O
on	on	IN	B-PP	O
antibiotic	antibiotic	JJ	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
off	off	IN	B-PP	O
pressors	pressor	NNS	B-NP	O
and	and	CC	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
daily	daily	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
off	off	IN	B-PP	O
all	all	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
trached	trache	VBN	I-VP	O
for	for	IN	B-PP	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
tolerating	tolerate	VBG	B-VP	O
trache	trache	NN	B-NP	O
collar	collar	NN	I-NP	O
and	and	CC	O	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
take	take	VB	I-VP	O
p.o.	p.o.	FW	B-NP	O
PAST	PAST	NNP	I-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
Morbid	Morbid	NNP	B-NP	O
obesity	obesity	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
ileojejunal	ileojejunal	JJ	I-NP	O
bypass	bypass	NN	I-NP	O
in	in	IN	B-PP	O
1972	1972	CD	B-NP	O
,	,	,	O	O
gastric	gastric	JJ	B-NP	O
stapling	stapling	NN	I-NP	O
in	in	IN	B-PP	O
1987	1987	CD	B-NP	O
,	,	,	O	O
obstructive	obstructive	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
apnea	apnea	NN	I-NP	O
,	,	,	O	O
on	on	IN	B-PP	O
home	home	NN	B-NP	B-DNA
3	3	CD	I-NP	I-DNA
liters	liter	VBZ	B-VP	O
nasal	nasal	JJ	B-NP	O
cannula	cannula	NN	I-NP	O
,	,	,	O	O
home	home	NN	B-NP	O
oxygen	oxygen	NN	I-NP	O
and	and	CC	I-NP	O
BiPAP	BiPAP	NN	I-NP	B-protein
,	,	,	O	O
asthma	asthma	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
,	,	,	O	O
a	a	DT	B-NP	O
MIBI	MIBI	NNP	I-NP	O
in	in	IN	B-PP	O
1998	1998	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
apical	apical	JJ	B-NP	O
anterior	anterior	JJ	I-NP	O
MI	MI	NN	I-NP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
stress-induced	stress-induced	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
anterior	anterior	JJ	I-NP	O
wall	wall	NN	I-NP	O
and	and	CC	O	O
lateral	lateral	JJ	B-NP	O
wall	wall	NN	I-NP	O
MI	MI	NN	I-NP	O
,	,	,	O	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
EF	EF	NN	I-NP	O
of	of	IN	B-PP	O
25	25	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
,	,	,	O	O
atrial	atrial	JJ	B-NP	O
flutter	flutter	NN	I-NP	O
with	with	IN	B-PP	O
Mobitz	Mobitz	NN	B-NP	B-protein
type	type	NN	I-NP	I-protein
II	II	CD	I-NP	I-protein
,	,	,	O	O
PE/DVT	PE/DVT	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
baseline	baseline	NN	I-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
,	,	,	O	O
BPH	BPH	NN	B-NP	O
,	,	,	O	O
gout	gout	NN	B-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
secondary	secondary	JJ	I-NP	O
erosive	erosive	JJ	I-NP	O
gastritis	gastritis	NN	I-NP	O
,	,	,	O	O
sigmoidectomy	sigmoidectomy	NN	B-NP	O
in	in	IN	B-PP	O
3/11	3/11	NN	B-NP	O
,	,	,	O	O
depression	depression	NN	B-NP	O
,	,	,	O	O
osteoarthritis	osteoarthritis	NN	B-NP	O
,	,	,	O	O
nephrolithiasis	nephrolithiasis	NN	B-NP	O
in	in	IN	B-PP	O
1/20	1/20	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
in	in	IN	B-PP	O
5/13	5/13	CD	B-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
hematuria	hematuria	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
AT	AT	NN	I-NP	O
HOME	HOME	NN	I-NP	O
:	:	:	O	O
Included	Include	VBN	B-VP	O
Lasix	Lasix	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
50	50	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
digoxin	digoxin	NN	B-NP	O
0.250	0.250	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Prevacid	Prevacid	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Flomax	Flomax	NN	B-NP	O
0.5	0.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
colchicine	colchicine	NN	B-NP	O
0.6	0.6	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
B12	B12	NN	B-NP	B-protein
1000	1000	CD	I-NP	I-protein
units	unit	NNS	I-NP	I-protein
IM	IM	VBP	B-VP	O
every	every	DT	B-NP	O
month	month	NN	I-NP	O
,	,	,	O	O
Roxicodone	Roxicodone	NN	B-NP	O
10-15	10-15	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
calcitriol	calcitriol	NN	B-NP	O
0.25	0.25	CD	I-NP	O
mcg	mcg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
lorazepam	lorazepam	NN	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
,	,	,	O	O
and	and	CC	O	O
Advair	Advair	NN	B-NP	O
250/50	250/50	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
Incudes	Incus	NNS	B-NP	O
erythromycin	erythromycin	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
gives	give	VBZ	B-VP	O
him	him	PRP	B-NP	O
hives	hive	VBZ	B-VP	O
,	,	,	O	O
penicillin	penicillin	NN	B-NP	O
hives	hive	NNS	I-NP	O
,	,	,	O	O
trazodone	trazodone	NN	B-NP	O
priapism	priapism	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
inhibitors	inhibitor	NNS	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
caused	cause	VBD	B-VP	O
angioedema	angioedema	NN	B-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
His	His	PRP$	B-NP	O
daughter	daughter	NN	I-NP	O
is	be	VBZ	B-VP	O
Mikel	Mikel	NNP	B-NP	O
Patek	Patek	NNP	I-NP	O
,	,	,	O	O
reached	reach	VBD	B-VP	O
at	at	IN	B-PP	O
538-039-8630	538-039-8630	CD	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
VNA	VNA	NN	B-NP	O
services	service	NNS	I-NP	O
at	at	IN	B-PP	O
home	home	NN	B-NP	O
,	,	,	O	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
nonsmoker	nonsmoker	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
alcohol	alcohol	NN	B-NP	O
abuse	abuse	NN	I-NP	O
.	.	.	O	O

FAMILY	FAMILY	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
Significant	Significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
mother	mother	NN	B-NP	O
with	with	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
and	and	CC	O	O
father	father	NN	B-NP	O
with	with	IN	B-PP	O
hypertension	hypertension	NN	B-NP	O
and	and	CC	I-NP	O
alcoholism	alcoholism	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
A	A	DT	B-NP	O
morbidly	morbidly	RB	I-NP	O
obese	obese	JJ	I-NP	O
African-American	African-American	JJ	I-NP	O
male	male	JJ	I-NP	O
trached	trache	VBN	B-VP	O
in	in	IN	B-PP	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

Pupils	Pupil	NNS	B-NP	O
were	be	VBD	B-VP	O
equally	equally	RB	B-ADVP	O
,	,	,	O	O
round	round	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
reactive	reactive	JJ	B-ADJP	O
to	to	TO	B-PP	O
light	light	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
oropharynx	oropharynx	NN	I-NP	O
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
with	with	IN	B-PP	O
moist	moist	JJ	B-NP	O
mucous	mucous	JJ	I-NP	O
membranes	membrane	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
chest	chest	NN	I-NP	O
has	have	VBZ	B-VP	O
vented	vent	VBN	I-VP	O
breath	breath	NN	B-NP	O
sounds	sound	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
heart	heart	NN	I-NP	O
is	be	VBZ	B-VP	O
S1	S1	NN	B-NP	B-protein
and	and	CC	O	O
S2	S2	NN	B-NP	B-protein
,	,	,	O	O
tachycardic	tachycardic	JJ	B-ADJP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
rubs	rub	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
sometimes	sometimes	RB	B-ADVP	O
irregularly	irregularly	RB	B-ADJP	O
irregular	irregular	JJ	I-ADJP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdomen	NN	I-NP	O
is	be	VBZ	B-VP	O
obese	obese	JJ	B-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
gallbladder	gallbladder	NN	I-NP	O
drain	drain	NN	I-NP	O
,	,	,	O	O
soft	soft	JJ	B-NP	O
,	,	,	I-NP	O
nontender	nontender	JJ	I-NP	O
,	,	,	I-NP	O
and	and	CC	I-NP	O
nondistended	nondistended	JJ	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
extremities	extremity	NNS	I-NP	O
are	be	VBP	B-VP	O
warm	warm	JJ	B-ADJP	O
and	and	CC	O	O
well	well	RB	B-ADJP	O
perfused	perfuse	VBN	I-ADJP	O
with	with	IN	B-PP	O
2	2	CD	B-NP	O
+	+	SYM	O	O
pitting	pit	VBG	B-VP	O
edema	edema	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
knees	knee	NNS	I-NP	O
bilaterally	bilaterally	RB	B-ADVP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
healing	heal	VBG	I-VP	O
vesicles	vesicle	NNS	B-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
nose	nose	NN	I-NP	O
and	and	CC	I-NP	O
lips	lip	NNS	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
septic	septic	JJ	B-NP	O
shock	shock	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
and	and	CC	O	O
acalculous	acalculous	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
quinolone-resistant	quinolone-resistant	JJ	B-NP	O
E.	E.	FW	I-NP	O
coli	coli	FW	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
desensitization	desensitization	NN	I-NP	O
protocol	protocol	NN	I-NP	O
for	for	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
to	to	TO	B-VP	O
treat	treat	VB	I-VP	O
E.	E.	FW	B-NP	O
coli	coli	FW	I-NP	O
,	,	,	O	O
completed	complete	VBD	B-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
ceftriaxone	ceftriaxone	NN	B-NP	O
for	for	IN	B-PP	O
urosepsis	urosepsis	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
biliary	biliary	JJ	I-NP	O
drain	drain	NN	I-NP	O
placed	place	VBN	B-VP	O
to	to	TO	I-VP	O
decompress	decompress	VB	I-VP	O
gallbladder	gallbladder	NN	B-NP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
right	right	JJ	I-NP	O
upper	upper	JJ	I-NP	O
quadrant	quadrant	JJ	I-NP	O
ultrasound	ultrasound	NN	I-NP	O
without	without	IN	B-PP	O
dilated	dilated	JJ	B-NP	O
ducts	duct	NNS	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
will	will	MD	B-VP	O
stay	stay	VB	I-VP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
for	for	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
14-day	14-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
empiric	empiric	JJ	B-NP	O
coverage	coverage	NN	I-NP	O
after	after	IN	B-PP	O
8/30/05	8/30/05	CD	B-NP	O
coag-negative	coag-negative	JJ	I-NP	O
Staph	Staph	NNP	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
line	line	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
,	,	,	O	O
as	as	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
febrile	febrile	JJ	B-ADJP	O
.	.	.	O	O

Other	Other	JJ	B-NP	O
surveillance	surveillance	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Vesicular	Vesicular	JJ	B-NP	O
lesions	lesion	NNS	I-NP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
nose	nose	NN	I-NP	O
and	and	CC	I-NP	O
lips	lip	NNS	I-NP	O
,	,	,	O	O
received	receive	VBD	B-VP	O
a	a	DT	B-NP	O
seven-day	seven-day	JJ	I-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
acyclovir	acyclovir	NN	B-NP	O
.	.	.	O	O

While	While	IN	B-SBAR	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cells	cell	NNS	I-NP	O
count	count	NN	I-NP	O
trending	trend	VBG	B-VP	O
down	down	RB	B-ADVP	O
and	and	CC	O	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
daily	daily	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
,	,	,	O	O
usually	usually	RB	B-ADVP	O
spiking	spike	VBG	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
afternoon	afternoon	NN	I-NP	O
and	and	CC	O	O
then	then	RB	B-ADVP	O
defervescing	defervesce	VBG	B-VP	O
without	without	IN	B-PP	O
medication	medication	NN	B-NP	O
throughout	throughout	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

LENIs	LENI	NNS	B-NP	B-protein
on	on	IN	B-PP	O
5/26/05	5/26/05	CD	B-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
DVTs	DVT	NNS	I-NP	O
,	,	,	O	O
although	although	IN	B-SBAR	O
limited	limit	VBN	B-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
galactomannan	galactomannan	NN	I-NP	O
was	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

Both	Both	CC	O	O
arterial	arterial	JJ	B-NP	O
line	line	NN	I-NP	O
and	and	CC	O	O
central	central	JJ	B-NP	O
line	line	NN	I-NP	O
changed	change	VBD	B-VP	O
2/4/05	2/4/05	CD	B-NP	O
,	,	,	O	O
eventually	eventually	RB	B-VP	O
taken	take	VBN	I-VP	O
out	out	IN	B-PRT	O
.	.	.	O	O

Fevers	Fever	NNS	B-NP	O
felt	feel	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
off	off	IN	B-PP	O
all	all	DT	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
with	with	IN	B-PP	O
gradual	gradual	JJ	B-NP	O
resolution	resolution	NN	I-NP	O
of	of	IN	B-PP	O
fevers	fever	NNS	B-NP	O
.	.	.	O	O

ENT	ENT	NN	B-NP	O
evaluated	evaluate	VBN	B-VP	O
for	for	IN	B-PP	O
sinusitis	sinusitis	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sinusitis	sinusitis	NN	I-NP	O
on	on	IN	B-PP	O
10/10/05	10/10/05	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
LFTs	LFT	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

Chest	Ch	JJS	B-NP	O
x-ray	x-ray	NN	I-NP	B-DNA
is	be	VBZ	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
yeast	yeast	NN	B-NP	O
.	.	.	O	O

Body	Body	JJ	B-NP	O
habitus	habitus	NN	I-NP	O
prevents	prevent	VBZ	B-VP	O
chest	chest	NN	B-NP	O
,	,	,	O	O
abdominal	abdominal	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
pelvic	pelvic	JJ	B-NP	O
CT	CT	NN	I-NP	O
scan	scan	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
trached	trache	VBN	I-VP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
extensive	extensive	JJ	B-NP	O
soft	soft	JJ	I-NP	O
tissue	tissue	NN	I-NP	O
and	and	CC	I-NP	O
concern	concern	NN	I-NP	O
for	for	IN	B-PP	O
airway	airway	NN	B-NP	O
collapse	collapse	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
tolerating	tolerate	VBG	B-VP	O
trach	trach	NN	B-NP	O
with	with	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
secretions	secretion	NNS	I-NP	O
when	when	WRB	B-ADVP	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
glycopyrrolate	glycopyrrolate	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
trache	trache	NN	I-NP	O
tube	tube	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
on	on	IN	B-PP	O
4/19/05	4/19/05	CD	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
Bivona	Bivona	NNP	I-NP	B-protein
#	#	#	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
known	know	VBN	B-NP	O
CAD	CAD	NN	I-NP	B-protein
,	,	,	O	O
on	on	IN	B-PP	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
consider	consider	VB	B-VP	O
restarting	restart	VBG	I-VP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
once	once	RB	B-ADJP	O
therapeutic	therapeutic	JJ	I-ADJP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
known	know	VBN	I-VP	O
ACE	ACE	NN	B-NP	O
inhibitor	inhibitor	NN	I-NP	O
allergy	allergy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
fasting	fast	VBG	I-NP	O
lipid	lipid	NN	I-NP	O
profiles	profile	NNS	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
,	,	,	B-PP	O
not	not	RB	I-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

Pump	Pump	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
on	on	IN	B-PP	O
2/4/05	2/4/05	CD	B-NP	O
that	that	WDT	B-NP	O
showed	show	VBD	B-VP	O
mild	mild	JJ	B-ADJP	O
to	to	TO	B-PP	O
moderately	moderately	RB	B-NP	O
reduced	reduce	VBN	I-NP	O
LV	LV	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

Unable	Unable	JJ	B-ADJP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
the	the	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
due	due	JJ	B-ADJP	O
to	to	TO	B-PP	O
limited	limited	JJ	B-NP	O
study	study	NN	I-NP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
size	size	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
posterior	posterior	JJ	I-NP	O
lateral	lateral	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
to	to	TO	B-PP	O
akinesis	akinesis	NN	B-NP	O
and	and	CC	O	O
abnormal	abnormal	JJ	B-NP	O
septal	septal	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
,	,	,	O	O
moderate	moderate	JJ	B-NP	O
tricuspid	tricuspid	JJ	I-NP	O
regurgitation	regurgitation	NN	I-NP	O
.	.	.	O	O

Volume	Volume	NN	B-NP	O
overloaded	overload	VBD	B-VP	O
,	,	,	O	O
diuresed	diurese	VBN	B-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
now	now	RB	B-ADJP	O
euvolemic	euvolemic	JJ	I-ADJP	O
,	,	,	O	O
autoregulating	autoregulate	VBG	B-VP	O
.	.	.	O	O

Rate	Rate	NN	B-NP	O
and	and	CC	I-NP	O
rhythm	rhythm	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
on	on	IN	B-PP	O
anticoagulation	anticoagulation	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
permanent	permanent	JJ	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
for	for	IN	B-PP	O
bradycardia	bradycardia	NN	B-NP	O
.	.	.	O	O

EP	EP	NN	B-NP	B-protein
increased	increase	VBD	B-VP	O
the	the	DT	B-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
from	from	IN	B-PP	O
60-80	60-80	CD	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
pacemaker	pacemaker	NN	I-NP	O
rate	rate	NN	I-NP	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
back	back	RB	B-ADVP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Medtronic	Medtronic	NNP	I-NP	O
pacemaker	pacemaker	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
DVT	DVT	NN	B-NP	O
,	,	,	O	O
PE	PE	NN	B-NP	O
,	,	,	O	O
now	now	RB	B-ADVP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
therapeutic	therapeutic	JJ	I-NP	O
INR	INR	NN	I-NP	O
goal	goal	NN	I-NP	O
of	of	IN	B-PP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
IVC	IVC	NN	I-NP	O
filter	filter	NN	I-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
biliary	biliary	JJ	B-NP	O
drain	drain	NN	I-NP	O
for	for	IN	B-PP	O
acalculous	acalculous	JJ	B-NP	O
cholecystitis	cholecystitis	NN	I-NP	O
to	to	TO	B-VP	O
remain	remain	VB	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
six	six	CD	B-NP	O
weeks	week	NNS	I-NP	O
by	by	IN	B-PP	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
placed	place	VBD	B-VP	O
on	on	IN	B-PP	O
11/6/05	11/6/05	CD	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
Acute	Acute	JJ	B-NP	O
and	and	CC	I-NP	O
chronic	chronic	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
after	after	IN	B-PP	O
sepsis	sepsis	NN	B-NP	O
.	.	.	O	O

Creatinine	Creatinine	NN	B-NP	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
after	after	IN	B-PP	O
diuresing	diurese	VBG	B-VP	O
post	post	NN	B-NP	O
ATN	ATN	NN	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-NP	O
ultrasound	ultrasound	NN	I-NP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Endo	Endo	NNP	B-NP	O
:	:	:	O	O
Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
dose	dose	NN	I-NP	O
Levoxyl	Levoxyl	NN	I-NP	O
for	for	IN	B-PP	O
hypothyroidism	hypothyroidism	NN	B-NP	O
.	.	.	O	O

Became	Became	NNP	B-NP	O
,	,	,	O	O
hyponatremic	hyponatremic	JJ	B-NP	O
,	,	,	I-NP	O
hyperkalemic	hyperkalemic	JJ	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
resolved	resolve	VBD	B-VP	O
on	on	IN	B-PP	O
its	its	PRP$	B-NP	O
own	own	JJ	I-NP	O
.	.	.	O	O

Cort-stim	Cort-stim	JJ	B-ADJP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
trache	trache	NN	I-NP	O
refusing	refuse	VBG	B-VP	O
OG/NG	OG/NG	NN	B-NP	O
tube	tube	NN	I-NP	O
.	.	.	O	O

Speech	Speech	NNP	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NNP	I-NP	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
would	would	MD	B-VP	O
tolerate	tolerate	VB	I-VP	O
p.o.	p.o.	NN	B-NP	O
and	and	CC	O	O
advanced	advance	VBN	B-NP	O
diet	diet	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

PPX	PPX	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
INR	INR	NN	I-NP	B-protein
and	and	CC	I-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
full	full	JJ	I-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Tylenol	Tylenol	NN	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
temperature	temperature	NN	I-NP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
albuterol	albuterol	NN	B-NP	O
inhaler	inhaler	NN	I-NP	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	B-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
diphenhydramine	diphenhydramine	NN	B-NP	O
HCL	HCL	NN	I-NP	O
25-50	25-50	CD	B-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
other	other	JJ	B-NP	O
allergic	allergic	JJ	I-NP	O
reaction	reaction	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
glycopyrrolate	glycopyrrolate	NN	B-NP	B-protein
1	1	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
p.o.	p.o.	FW	I-NP	I-protein
t.i.d.	t.i.d.	NN	I-NP	I-protein
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
Lacrilube	Lacrilube	NNP	B-NP	O
topical	topical	JJ	I-NP	O
each	each	DT	B-NP	O
eye	eye	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Levoxyl	Levoxyl	NN	B-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
1-2	1-2	CD	I-NP	O
mg	mg	NN	I-NP	O
IV	IV	CD	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
anxiety	anxiety	NN	I-NP	O
,	,	,	O	O
Ativan	Ativan	NNP	B-NP	O
1	1	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
25	25	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
;	;	:	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
systolic	systolic	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
90	90	CD	I-NP	O
and	and	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
50	50	CD	B-NP	O
,	,	,	O	O
oxycodone	oxycodone	NN	B-NP	O
5-10	5-10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
Pyridium	Pyridium	NN	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
bladder	bladder	NN	I-NP	O
spasm	spasm	NN	I-NP	O
,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
therapeutic	therapeutic	JJ	B-ADJP	O
with	with	IN	B-PP	O
minerals	mineral	NNS	B-NP	O
one	one	CD	B-NP	O
tablet	tablet	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
vitamin	vitamin	NN	B-NP	O
A	A	NN	I-NP	O
10	10	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
units	unit	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
daily	daily	JJ	I-NP	O
x7	x7	NN	I-NP	O
doses	dose	NNS	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
4/19/05	4/19/05	CD	B-NP	O
,	,	,	O	O
Coumadin	Coumadin	NN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Zinc	Zinc	NN	B-NP	O
sulfate	sulfate	NN	I-NP	O
220	220	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
daily	daily	JJ	I-NP	O
x14	x14	NN	I-NP	O
doses	dose	NNS	I-NP	O
started	start	VBD	B-VP	O
on	on	IN	B-PP	O
4/19/05	4/19/05	CD	B-NP	O
,	,	,	O	O
Zoloft	Zoloft	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
should	should	MD	B-VP	O
be	be	VB	I-VP	O
titrated	titrate	VBN	I-VP	O
up	up	IN	B-NP	O
to	to	TO	I-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
,	,	,	O	O
fluticasone	fluticasone	NN	B-NP	O
110	110	CD	I-NP	O
mcg	mcg	NN	I-NP	O
inhaler	inhaler	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
2	2	CD	I-NP	O
%	%	NN	I-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Combivent	Combivent	NNP	B-NP	O
6	6	CD	I-NP	O
puffs	puff	NNS	I-NP	O
inhaler	inhal	JJR	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
Nexium	Nexium	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
in	in	IN	B-PP	O
stable	stable	JJ	B-NP	O
condition	condition	NN	I-NP	O
,	,	,	O	O
full	full	JJ	B-NP	O
code	code	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
5-3901410	5-3901410	CD	B-NP	O
EMS	EMS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
LATAILLE	LATAILLE	NN	B-NP	O
,	,	,	O	O
PAT	PAT	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MARITATO	MARITATO	NNP	B-NP	O
,	,	,	O	O
SHERMAN	SHERMAN	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
5486503	5486503	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
5/10/05	5/10/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
5/10/05	5/10/05	CD	B-NP	O

